Sites: CDL-Oxford, CDL-Toronto, CDL-Vancouver, CDL-Wisconsin
Stream: Advanced Therapies
Greg Bonfiglio was an early investor in the field of stem cells and regenerative medicine (RM) and continues to actively invest in the field. Greg is the Chair of the board of the Centre for Commercialization of Regenerative Medicine and has served on the boards of several RM companies, including VistaGen Therapeutics, California Stem Cell, and StemCyte Inc. From 2000– 2005, Greg was a general partner with Anthem Venture Partners, an early-stage venture fund in California. Greg led Anthem’s investment in advanced cell technology in 2000, helping to take the company public in 2005.